Jose Castillo-Mancilla
Infectious Disease · Aurora, CONPI 1437136462
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 2 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. That places this record below the midpoint for infectious disease clinicians in CO, where the typical reported total is $129.
Across 2 payments — averaging $17.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$19
- Boston Scientific$15
Across 41 payments — averaging $509,800 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Viiv Healthcare Company$20.7M
- Gilead$219K
What the payments were for
- Food & beverage$34100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 1 | $19 |
| Boston Scientific | 1 | $15 |
How this compares
$34 in reported general payments places this provider in the 30th percentile of 146 infectious disease providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 55 | $196,312 |
| DescovyEmtricitabine/Tenofov Alafenam | 50 | $100,348 |
| IsentressRaltegravir Potassium | 50 | $83,909 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 13 | $54,122 |
| TriumeqAbacavir/Dolutegravir/Lamivudi | 16 | $53,029 |
| TivicayDolutegravir Sodium | 21 | $46,613 |
| Abacavir-LamivudineAbacavir Sulfate/Lamivudine | 12 | $6,902 |
| AbacavirAbacavir Sulfate | 16 | $3,626 |
| Ritonavir | 12 | $2,556 |
| Lamivudine | 11 | $869 |
| Duloxetine Hcl | 12 | $337 |
| Acyclovir | 17 | $218 |
| Atorvastatin Calcium | 55 | $197 |
| Bupropion Hcl SrBupropion Hcl | 13 | $159 |
| FenofibrateFenofibrate Nanocrystallized | 12 | $101 |
Paid to pharmacies, not to this prescriber.
Other infectious disease in Aurora
- Kristine ErlandsonAurora$88K
- Adriana WeinbergAurora$36K
- Carlos Franco ParedesAurora$25K
- Steven JohnsonAurora$24K
- Cynthia FirnhaberAurora$18K
- Edward StenehjemAurora$15K
- Thomas CampbellAurora$11K
- Andres Henao MartinezAurora$7K
- Edward JanoffAurora$3K
- Hillary DunlevyAurora$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.